| Died | Alive | P | logistics |
n | 80 | 494 |
| |
Age, median [Q1, Q3] | 63.0 [54.00, 71.25] | 53.00 [42.00, 64.00] | <0.001 | <0.001 |
Male, n | 48 | 304 | 0.805 |
|
Male, (%) | 60.00% | 61.54% | ||
ethnicity |
| |||
white, n | 48 | 297 |
| |
white, (%) | 60.00% | 60.12% | ||
BLACK/AFRICAN AMERICAN, n | 6 | 63 | ||
BLACK/AFRICAN AMERICAN, (%) | 7.50% | 12.75% | ||
AMERICAN INDIAN/ALASKA NATIVE, n | 0 | 2 | ||
AMERICAN INDIAN/ALASKA NATIVE, (%) | 0.00% | 0.40% | ||
PORTUGUESE, n | 0 | 5 | ||
PORTUGUESE, (%) | 0.00% | 1.01% | ||
UNKNOWN, n | 12 | 58 | ||
UNKNOWN, (%) | 15.00% | 11.74% | ||
ASIAN, n | 6 | 14 | ||
ASIAN, (%) | 7.50% | 2.83% | ||
OTHER, n | 2 | 21 | ||
OTHER, (%) | 2.50% | 4.25% | ||
HISPANIC/LATINO, n | 0 | 25 | ||
HISPANIC/LATINO, (%) | 0.00% | 5.06% | ||
UNABLE TO OBTAIN, n | 6 | 9 | ||
UNABLE TO OBTAIN, (%) | 7.50% | 1.82% | ||
ApsⅢ, median [Q1, Q3] | 95.50 [71.75, 112.25] | 55.00 [39.00, 76.00] | <0.001 | <0.001 |
inSOFA, median [Q1, Q3] | 4.00 [1.00, 7.00] | 1.00 [0, 3.00] | <0.001 | <0.001 |
▲SOFA, median [Q1, Q3] | 4.00 [2.00, 9.25] | 0 [−1.00, 2.00] | <0.001 |
|
Glu_meana (mmol/L), median [Q1, Q3] | 8.88 [7.69, 10.31] | 7.63 [6.47, 9.11] | <0.001 | 0.104 |
Glu_cvb, median [Q1, Q3] | 0.34 [0.24, 0.41] | 0.22 [0.16, 0.31] | <0.001 | 0.151 |
Glu_frequency* (n/day), median [Q1, Q3] | 5.50 [4.32, 7.34] | 4.52 [3.24, 6.22] | <0.001 | 0.652 |
LOS in ICUc, median [Q1, Q3] | 8.58 [4.48, 19.09] | 4.43 [2.92, 9.97] | <0.001 |
|
LOS in hospitald, median [Q1, Q3] | 17.16 [8.44, 29.01] | 15.57 [8.81, 25.59] | 0.536 | |
infection, n | 52 | 213 | <0.001 | 0.221 |
infection, (%) | 65.00% | 43.12% |